← Open Payments lookup

EMILY SWARTLEY: Open Payments

NPI 1417523192 · WATERLOO, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$867 in 91 payments from 13 companies in 2025. Trend: 2023 $1,495 · 2024 $807 · 2025 $867

Food & beverage: $867
CompanyPaymentsAmount
ABBVIE INC.39$232
Neurocrine BioSciences, Inc.26$155
E.R. Squibb & Sons, L.L.C.4$113
Axsome Therapeutics, Inc.5$57
Otsuka America Pharmaceutical, Inc.3$56
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$49
Alkermes, Inc.3$47
Teva Pharmaceuticals USA, Inc.2$33
Janssen Pharmaceuticals, Inc2$33
Vanda Pharmaceuticals Inc.1$32

Products named: VRAYLAR, INGREZZA, COBENFY, Auvelity, REXULTI, CAPLYTA, ARISTADA, INVEGA SUSTENNA.

Industry payments across IA — which companies pay providers there.